<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35341712</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-7500</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>The Lancet. Digital health</Title><ISOAbbreviation>Lancet Digit Health</ISOAbbreviation></Journal><ArticleTitle>Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study.</ArticleTitle><Pagination><StartPage>e359</StartPage><EndPage>e369</EndPage><MedlinePgn>e359-e369</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2589-7500(21)00274-0</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2589-7500(21)00274-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is known to represent a collection of overlapping syndromes. Various classification systems based on empirical observations have been proposed, but it is unclear to what extent they reflect ALS population substructures. We aimed to use machine-learning techniques to identify the number and nature of ALS subtypes to obtain a better understanding of this heterogeneity, enhance our understanding of the disease, and improve clinical care.</AbstractText><AbstractText Label="METHODS">In this retrospective study, we applied unsupervised Uniform Manifold Approximation and Projection [UMAP]) modelling, semi-supervised (neural network UMAP) modelling, and supervised (ensemble learning based on LightGBM) modelling to a population-based discovery cohort of patients who were diagnosed with ALS while living in the Piedmont and Valle d'Aosta regions of Italy, for whom detailed clinical data, such as age at symptom onset, were available. We excluded patients with missing Revised ALS Functional Rating Scale (ALSFRS-R) feature values from the unsupervised and semi-supervised steps. We replicated our findings in an independent population-based cohort of patients who were diagnosed with ALS while living in the Emilia Romagna region of Italy.</AbstractText><AbstractText Label="FINDINGS">Between Jan 1, 1995, and Dec 31, 2015, 2858 patients were entered in the discovery cohort. After excluding 497 (17%) patients with missing ALSFRS-R feature values, data for 42 clinical features across 2361 (83%) patients were available for the unsupervised and semi-supervised analysis. We found that semi-supervised machine learning produced the optimum clustering of the patients with ALS. These clusters roughly corresponded to the six clinical subtypes defined by the Chi&#xf2; classification system (ie, bulbar, respiratory, flail arm, classical, pyramidal, and flail leg ALS). Between Jan 1, 2009, and March 1, 2018, 1097 patients were entered in the replication cohort. After excluding 108 (10%) patients with missing ALSFRS-R feature values, data for 42 clinical features across 989 patients were available for the unsupervised and semi-supervised analysis. All 1097 patients were included in the supervised analysis. The same clusters were identified in the replication cohort. By contrast, other ALS classification schemes, such as the El Escorial categories, Milano-Torino clinical staging, and King's clinical stages, did not adequately label the clusters. Supervised learning identified 11 clinical parameters that predicted ALS clinical subtypes with high accuracy (area under the curve 0&#xb7;982 [95% CI 0&#xb7;980-0&#xb7;983]).</AbstractText><AbstractText Label="INTERPRETATION">Our data-driven study provides insight into the ALS population substructure and confirms that the Chi&#xf2; classification system successfully identifies ALS subtypes. Additional validation is required to determine the accuracy and clinical use of these algorithms in assigning clinical subtypes. Nevertheless, our algorithms offer a broad insight into the clinical heterogeneity of ALS and help to determine the actual subtypes of disease that exist within this fatal neurodegenerative syndrome. The systematic identification of ALS subtypes will improve clinical care and clinical trial design.</AbstractText><AbstractText Label="FUNDING">US National Institute on Aging, US National Institutes of Health, Italian Ministry of Health, European Commission, University of Torino Rita Levi Montalcini Department of Neurosciences, Emilia Romagna Regional Health Authority, and Italian Ministry of Education, University, and Research.</AbstractText><AbstractText Label="TRANSLATIONS">For the Italian and German translations of the abstract see Supplementary Materials section.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faghri</LastName><ForeName>Faraz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, US National Institute on Aging, Bethesda, MD, USA; Center for Alzheimer's and Related Dementias, US National Institute on Aging, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA; Department of Computer Science, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunn</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dadu</LastName><ForeName>Anant</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Alzheimer's and Related Dementias, US National Institute on Aging, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA; Department of Computer Science, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PARALS consortium</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>ERRALS consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Zucchi</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Neurosciences, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neurology, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rita Levi Montalcini, Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rita Levi Montalcini, Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rita Levi Montalcini, Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rita Levi Montalcini, Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalls</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Alzheimer's and Related Dementias, US National Institute on Aging, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Roy H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandrioli</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Neurology Unit, Department of Neurosciences, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traynor</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, US National Institute on Aging, Bethesda, MD, USA; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, University College London, London, UK. Electronic address: traynorb@mail.nih.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rita Levi Montalcini, Department of Neuroscience, University of Turin, Turin, Italy; Institute of Cognitive Sciences and Technologies, CNR, Rome, Italy; Neurology 1 and ALS Centre, Azienda Ospedaliero Universitaria Citt&#xe0; della Salute e della Scienza, Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z99 AG999999</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Digit Health</MedlineTA><NlmUniqueID>101751302</NlmUniqueID><ISSNLinking>2589-7500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests BJT holds patents on the clinical testing and therapeutic intervention for the hexanucleotide repeat expansion of C9orf72 (patent numbers EP2751284A1, CA2846307A, and 20180187262); received research grants from the Myasthenia Gravis Foundation, ALS Association, US Center for Disease Control and Prevention, US Department of Veterans Affairs, MSD, and Cerevel Therapeutics; receives funding through the Intramural Research Program at the US National Institutes of Health (NIH), is on the scientific advisory committee of the American Neurological Association, is an associate editor of Brain, and is on the editorial boards of Journal of Neurology, Neurosurgery, and Psychiatry, Neurobiology of Aging, and eClinicalMedicine. JM received research grants from the Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica, Agenzia Italiana del Farmaco, Italian Ministry of Health, Emilia Romagna Regional Health Authority, and Pfizer. ACh received research funding and honoraria for lectures from Biogen; sits on advisory boards for Mitsubishi Tanabe Pharma, Roche, Denali Therapeutics, Cytokinetics, Biogen, Amylyx Pharmaceuticals, and Sanofi; and participates in data safety monitoring boards for Lilly and AB Science. RV received research scholarship funding from the Rotary Club (global grant GG2094854). FF is employed by Data Tecnica International. MAN is employed by Data Tecnica International and is an adviser for Clover Therapeutics and Neuron23. AD is employed by Data Tecnica International. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manera</LastName><ForeName>Umberto</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palumbo</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bombaci</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grassano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Casale</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuda</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salamone</LastName><ForeName>Paolina</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iazzolino</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peotta</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cugnasco</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Marco</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torrieri</LastName><ForeName>Maria Claudia</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallone</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barberis</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sbaiz</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gentile</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mauro</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corrado</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Alfonso</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bertolotto</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Imperiale</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Mattei</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amar&#xf9;</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Comi</LastName><ForeName>Cristoforo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labate</LastName><ForeName>Carmelo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poglio</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Testa</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rota</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghiglione</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Launaro</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Sapio</LastName><ForeName>Alessia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mandrioli</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fini</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zucchi</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gianferrari</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simonini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meletti</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liguori</LastName><ForeName>Rocco</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vacchiano</LastName><ForeName>Veria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salvi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartolomei</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Michelucci</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cortelli</LastName><ForeName>Pietro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borghi</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sette</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tugnoli</LastName><ForeName>Valeria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pugliatti</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canali</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Codeluppi</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valzania</LastName><ForeName>Franco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zinno</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pavesi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Medici</LastName><ForeName>Doriana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pilurzi</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Terlizzi</LastName><ForeName>Emilio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guidetti</LastName><ForeName>Donata</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Pasqua</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santangelo</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Massis</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bracaglia</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Casmiro</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Querzani</LastName><ForeName>Pietro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morresi</LastName><ForeName>Simonetta</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Longoni</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patuelli</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malag&#xf9;</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Curr&#xf2; Dossi</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidale</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferro</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>28</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35341712</ArticleId><ArticleId IdType="mid">NIHMS1794804</ArticleId><ArticleId IdType="pmc">PMC9038712</ArticleId><ArticleId IdType="doi">10.1016/S2589-7500(21)00274-0</ArticleId><ArticleId IdType="pii">S2589-7500(21)00274-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the &#x201c;common&#x201d; neurologic disorders? Neurology 2007; 68: 326&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pubmed">17261678</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Bede P, Elamin M, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011; 12: 157&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">21208036</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012; 135: 847&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008; 119: 497&#x2013;503</Citation><ArticleIdList><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci 1994; 124 Suppl: 96&#x2013;107</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Piemonte, Valle d&#x2019;Aosta Register for Amyotrophic Lateral S. Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 2001; 56: 239&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">11160962</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Biguzzi S, Guidi C, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. Amyotroph Lateral Scler Frontotemporal Degener 2014; 15: 262&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">24863640</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2015; 86: 38&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999; 169: 13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta L, Santaniello A. Nearest neighbor imputation algorithms: a critical evaluation. BMC Med Inform Decis Mak 2016; 16 Suppl 3: 74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4959387</ArticleId><ArticleId IdType="pubmed">27454392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, Mazzini L, Mora G, group Ps. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011; 82: 740&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes L, Healy J, Saul N, Gro&#xdf;berger L. UMAP: Uniform Manifold Approximation and Projection. Journal of Open Source Software 2018; 3: 861</Citation></Reference><Reference><Citation>Sainburg T, McInnes L, Gentner TQ. Parametric UMAP embeddings for representation and semi-supervised learning. arXiv 2021; arXiv: 2009.12981v3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516496</ArticleId><ArticleId IdType="pubmed">34474477</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarious MB, Leonard HL, Vitale D, et al. GenoML: Automated Machine Learning for Genomics. arXiv 2021; arXiv:2103.03221v1</Citation></Reference><Reference><Citation>Breiman L. Random Forests. Machine Learning 2001; 45: 5&#x2013;32</Citation></Reference><Reference><Citation>Ke G, Meng Q, Finley T. LightGBM: A Highly Efficient Gradient Boosting Decision Tree. In: G I, L UV, B S, eds. Advances in Neural Information Processing Systems: Curran Associates, Inc., Red Hook; 2017: 3146&#x2013;54.</Citation></Reference><Reference><Citation>Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. New York: ACM; 2016: 785&#x2013;94.</Citation></Reference><Reference><Citation>Lundberg S, Lee S. A unified approach to interpreting model predictions. In: G I, L UV, B S, et al., editors. 31st Conference on Neural Information Processing Systems (NIPS 2017); Long Beach, CA, USA: Curran Associates, Inc, Red Hook. p. 4765&#x2013;74.</Citation></Reference><Reference><Citation>Rokach L Ensemble-based classifiers. Artificial Intelligence Review 2010; 33: 1&#x2013;39</Citation></Reference><Reference><Citation>Kueffner R, Zach N, Bronfeld M, et al. Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach. Sci Rep 2019; 9: 690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345935</ArticleId><ArticleId IdType="pubmed">30679616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuffner R, Zach N, Norel R, et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat Biotechnol 2015; 33: 51&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">25362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang M, Gao C, Goutman SA, et al. Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering. Neuroinformatics 2019; 17: 407&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527505</ArticleId><ArticleId IdType="pubmed">30460455</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Chat GL, Secchi-Buhour MS, et al. Development and validation of a 1-year survival prognosis estimation model for Amyotrophic Lateral Sclerosis using manifold learning algorithm UMAP. Sci Rep 2020; 10: 13378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414917</ArticleId><ArticleId IdType="pubmed">32770027</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu-Jones BK, Greene CS, Pooled Resource Open-Access ALSCTC. Semi-supervised learning of the electronic health record for phenotype stratification. J Biomed Inform 2016; 64: 168&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pubmed">27744022</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O. Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol 2015; 262: 1447&#x2013;54 26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469087</ArticleId><ArticleId IdType="pubmed">25860344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong ML, Tan PF, Holbrook JD. Predicting functional decline and survival in amyotrophic lateral sclerosis. PLoS One 2017; 12: e0174925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5390993</ArticleId><ArticleId IdType="pubmed">28406915</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl SR, Kim RB, Coan GS, Mitchell CS. Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction. Front Neuroinform 2018; 12: 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6010549</ArticleId><ArticleId IdType="pubmed">29962944</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Debray TPA, Visser AE, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 2018; 17: 423&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard H, Blauwendraat C, Krohn L, et al. Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson&#x2019;s disease. J Med Genet 2020; 57: 331&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474559</ArticleId><ArticleId IdType="pubmed">31784483</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Berry J, Shui A, et al. The PRO-ACT database: design, initial analyses, and predictive features. Neurology 2014; 83: 1719&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4239834</ArticleId><ArticleId IdType="pubmed">25298304</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>